ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,161 | +99.4% | 4,053 | +136.5% | 0.00% | – |
| Q2 2023 | $1,585 | +29.9% | 1,714 | +53.2% | 0.00% | – |
| Q1 2023 | $1,220 | -10.8% | 1,119 | +19.4% | 0.00% | – |
| Q4 2022 | $1,368 | -99.7% | 937 | +122.0% | 0.00% | – |
| Q3 2022 | $454,000 | -87.2% | 422 | -79.8% | 0.00% | – |
| Q2 2022 | $3,556,000 | -79.0% | 2,092 | -46.9% | 0.00% | – |
| Q1 2019 | $16,929,000 | -25.2% | 3,937 | 0.0% | 0.00% | – |
| Q4 2018 | $22,638,000 | -83.8% | 3,937 | -61.8% | 0.00% | – |
| Q3 2018 | $139,695,000 | +14.2% | 10,302 | 0.0% | 0.00% | – |
| Q2 2018 | $122,285,000 | – | 10,302 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 15,832,611 | $68,080,000 | 3.54% |
| Matrix Capital Management Company, LP | 28,000,000 | $120,400,000 | 3.21% |
| Virtus ETF Advisers LLC | 50,655 | $218,000 | 0.46% |
| TFG Asset Management GP Ltd | 500,000 | $2,150,000 | 0.27% |
| Rock Springs Capital Management LP | 800,000 | $3,440,000 | 0.13% |
| Orbimed Advisors | 1,350,655 | $5,808,000 | 0.09% |
| Vident Investment Advisory, LLC | 289,340 | $1,244,000 | 0.07% |
| WS MANAGEMENT LLLP | 185,537 | $798,000 | 0.05% |
| Rathbones Group PLC | 285,722 | $1,229,000 | 0.04% |
| Tekla Capital Management LLC | 228,496 | $983,000 | 0.04% |